secwatch.observer — SEC 8-K summary
======================================

Issuer:     CYTOKINETICS INC (CYTK)
CIK:        0001061983
Form:       8-K
Filed at:   2023-05-11T23:59:59+00:00
Accession:  0000950170-23-020843
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Cytokinetics annual meeting approves all proposals including director exculpation amendments
--------------------------------------------------------------------------------

- Three Class I directors elected: Kaye (53.7M for), Wierenga (79.0M for), Wysenski (81.9M for).
- Director exculpation amendment approved (84.1M for, 2.2M against).
- Officer exculpation amendment approved (74.0M for, 12.3M against).
- Ratified Ernst & Young as independent auditor for FY2023 (88.9M for).
- Advisory vote on exec compensation approved (83.1M for); say-on-pay frequency set to 1 year (86.0M).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1061983/000095017023020843/0000950170-23-020843-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1061983/000095017023020843/cytk-20230510.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-020843

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer